Neoadjuvant chemotherapy was shown to induce release of microvesicles from breast cancer cells containing more CCL2 molecules; it also enhanced infiltration of Ly6C+CCR2+ monocytes recruitment in the lung pre-metastatic site (72). This evidence concerns the gene CCL2 and breast cancer.